A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

432

Participants

Timeline

Start Date

July 13, 2015

Primary Completion Date

July 2, 2016

Study Completion Date

July 16, 2016

Conditions
Chronic Kidney Disease (CKD)
Interventions
BIOLOGICAL

Epoetin Hospira Arm

Epoetin Hospira Arm: Epoetin Hospira will be administered intravenously (IV) per the analogous version of the Fresenius Medical Care North America (FMCNA) cMAB 1 (inclusive of version 1.0, 1.1,...)erythropoietin stimulating agents (ESA) dosing algorithm for Epoetin Hospira for 24 weeks. Subjects will have Epoetin Hospira initiated using the same ESA dose level and frequency of administration for Epogen prior to randomization into the trial. Subjects will also receive IV iron per the FMCNA protocol that is standard of care at FMCNA clinics.

OTHER

Standard of Care Arm

Standard of care arm: No interventions will be performed in this arm for the clinical study; and subjects will receive ongoing standard of care, which includes Epogen administered IV per the FMCNA cMAB 5 (inclusive of versions 5.0, 5.1,....) ESA dosing algorithm and IV iron per the FMCNA protocol that is standard of care, at FMCNA clinics during the contemporaneous 24 week period.

DRUG

IV Iron

Subjects will also receive IV iron per the FMCNA protocol that is standard of care at FMCNA clinics.

Trial Locations (45)

19118

Delaware Valley Nephrology and Hypertension Associates, PC, Philadelphia

19446

Fresenius Medical Care- Lansdale Dialysis, Lansdale

27703

Briggs Avenue Dialysis Center, Durham

27704

Durham Nephrology Associates, Durham

28105

FMC Matthews, Matthews

28204

FMC Charlotte, Charlotte

Metrolina Nephrology Associates, PA, Charlotte

33609

Fresenius Medical Care, Tampa

33610

Fresenius Medical Care, Tampa

33614

Genesis Clinical Research, LLC, Tampa

37067

Fresenius Medical Care-Franklin, Franklin

37205

Nephrology Associates, PC, Nashville

37923

Knoxville Kidney Center, PLLC, Knoxville

37934

Fresenius Dialysis West, Knoxville

38555

Fresenius Crossville Dialysis Unit, Crossville

39501

North Gulfport, Gulfport

39503

South Mississippi Kidney Center, Gulfport

39530

Fresenius Medical Care, Biloxi Dialysis Unit, Biloxi

49001

Fresenius Medical Care-Kalamazoo East, Kalamazoo

49007

Paragon Health PC DBA Nephrology Center, Kalamazoo

49009

Fresenius Medical Care-Oshtemo, Kalamazoo

77083

Mission Bend Dialysis (FMC#3971), Houston

77099

Southwest Houston Research, Ltd., Houston

77471

Rosenberg Dialysis (FMC#1197), Rosenberg

78503

Gamma Medical Research Inc, McAllen

78596

Fresenius Medical Care Weslaco, Weslaco

78758

Fresenius Medical Care - Austin North 4478, Austin

Research Management Inc, Austin

83605

Frenova Renal Research, Caldwell

Fresenius Medical Care North America - Liberty Dialysis, Caldwell

83642

Frenova Renal Research, Meridian

Fresenius Medical Care North America - Liberty Dialysis, Meridian

83686

Frenova Renal Research, Nampa

Fresenius Medical Care North America - Liberty Dialysis, Nampa

83702

Frenova Renal Research, Boise

Fresenius Medical Care North America - Liberty Dialysis, Boise

91910

California Institute of Renal Research, Chula Vista

92064

California Institute of Renal Research at Fresenius Medical Care, Poway

92111

California Institute of Renal Research at Fresenius Medical Care Kearny Mesa, San Diego

92127

Fresenius Medical Care Rancho, Rancho Bernardo

92139

Fresenius Medical Care Paradise Valley, San Diego

02886

Fresenius Medical Care, Warwick

00983

Fresenius Medical Care Carolina, Carolina

00791

Fresenius Medical Care, Humacao

00917

Fresenius Medical Care San Juan, San Juan

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Pfizer

INDUSTRY

NCT02504294 - A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis | Biotech Hunter | Biotech Hunter